SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:kth-320243"
 

Search: onr:"swepub:oai:DiVA.org:kth-320243" > A pathogenic proteo...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

A pathogenic proteolysis-resistant huntingtin isoform induced by an antisense oligonucleotide maintains huntingtin function

Kim, Hyeongju (author)
Korea Adv Inst Sci & Technol KAIST, Dept Biol Sci, KI BioCentury, Daejeon, South Korea.
Lenoir, Sophie (author)
Univ Grenoble Alpes, CHU Grenoble Alpes, INSERM, U1216,Grenoble Inst Neurosci, Grenoble, France.
Helfricht, Angela (author)
ProQR Therapeut NV, Leiden, Netherlands.
show more...
Jung, Taeyang (author)
KTH,Strukturell bioteknik,Korea Adv Inst Sci & Technol KAIST, Dept Biol Sci, KI BioCentury, Daejeon, South Korea.
Karneva, Zhana K. (author)
ProQR Therapeut NV, Leiden, Netherlands.
Lee, Yejin (author)
Korea Adv Inst Sci & Technol KAIST, Dept Biol Sci, KI BioCentury, Daejeon, South Korea.
Beumer, Wouter (author)
ProQR Therapeut NV, Leiden, Netherlands.
Horst, Geert B. van der (author)
ProQR Therapeut NV, Leiden, Netherlands.
Anthonijsz, Herma (author)
ProQR Therapeut NV, Leiden, Netherlands.
Buil, Levi C. M. (author)
ProQR Therapeut NV, Leiden, Netherlands.
Ham, Frits van der (author)
ProQR Therapeut NV, Leiden, Netherlands.
Platenburg, Gerard J. (author)
ProQR Therapeut NV, Leiden, Netherlands.
Purhonen, Pasi (author)
KTH,Strukturell bioteknik
Hebert, Hans (author)
KTH,Strukturell bioteknik,Dept Biomed Engn & Hlth Syst, S-14152 Huddinge, Sweden.
Humbert, Sandrine (author)
Univ Grenoble Alpes, CHU Grenoble Alpes, INSERM, U1216,Grenoble Inst Neurosci, Grenoble, France.;Univ Grenoble Alpes, Grenoble Inst Neurosci, INSERM, U1216,CHU Grenoble Alpes,, F-38000 Grenoble, France.
Saudou, Frederic (author)
Univ Grenoble Alpes, CHU Grenoble Alpes, INSERM, U1216,Grenoble Inst Neurosci, Grenoble, France.;Univ Grenoble Alpes, Grenoble Inst Neurosci, INSERM, U1216,CHU Grenoble Alpes,, F-38000 Grenoble, France.
Klein, Pontus (author)
ProQR Therapeut NV, Leiden, Netherlands.;ProQR Therapeut NV, NL-2333 CK Leiden, Netherlands.
Song, Ji-Joon (author)
Korea Adv Inst Sci & Technol KAIST, Dept Biol Sci, KI BioCentury, Daejeon, South Korea.;291 Daehakro, Daejeon 34141, South Korea.
show less...
Korea Adv Inst Sci & Technol KAIST, Dept Biol Sci, KI BioCentury, Daejeon, South Korea Univ Grenoble Alpes, CHU Grenoble Alpes, INSERM, U1216,Grenoble Inst Neurosci, Grenoble, France. (creator_code:org_t)
2022-09-08
2022
English.
In: JCI Insight. - : American Society for Clinical Investigation. - 2379-3708. ; 7:17
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Huntington's disease (HD) is a late-onset neurological disorder for which therapeutics are not available. Its key pathological mechanism involves the proteolysis of polyglutamine-expanded (polyQ-expanded) mutant huntingtin (mHTT), which generates N-terminal fragments containing polyQ, a key contributor to HD pathogenesis. Interestingly, a naturally occurring spliced form of HTT mRNA with truncated exon 12 encodes an HTT (HTT & UDelta;12) with a deletion near the caspase-6 cleavage site. In this study, we used a multidisciplinary approach to characterize the therapeutic potential of targeting HTT exon 12. We show that HTT & UDelta;12 was resistant to caspase-6 cleavage in both cell-free and tissue lysate assays. However, HTT & UDelta;12 retained overall biochemical and structural properties similar to those of wt-HTT. We generated mice in which HTT exon 12 was truncated and found that the canonical exon 12 was dispensable for the main physiological functions of HTT, including embryonic development and intracellular trafficking. Finally, we pharmacologically induced HTT & UDelta;12 using the antisense oligonucleotide (ASO) QRX-704. QRX-704 showed predictable pharmacology and efficient biodistribution. In addition, it was stable for several months and inhibited pathogenic proteolysis. Furthermore, QRX-704 treatments resulted in a reduction of HTT aggregation and an increase in dendritic spine count. Thus, ASO-induced HTT exon 12 splice switching from HTT may provide an alternative therapeutic strategy for HD.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view